|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
ATE243754T1
(de)
|
1987-05-21 |
2003-07-15 |
Micromet Ag |
Multifunktionelle proteine mit vorbestimmter zielsetzung
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
WO1989009622A1
(en)
|
1988-04-15 |
1989-10-19 |
Protein Design Labs, Inc. |
Il-2 receptor-specific chimeric antibodies
|
|
ATE120454T1
(de)
|
1988-06-14 |
1995-04-15 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
IE63847B1
(en)
|
1989-05-05 |
1995-06-14 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
AU654811B2
(en)
|
1990-03-20 |
1994-11-24 |
Trustees Of Columbia University In The City Of New York, The |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
DE69133036T2
(de)
|
1990-11-09 |
2003-02-06 |
Stephen D. Gillies |
Cytokine immunokonjugate
|
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
|
FR2686087A1
(fr)
|
1992-01-13 |
1993-07-16 |
Inst Nat Sante Rech Med |
Nouvel antigene lymphocytaire, anticorps correspondant et leurs applications.
|
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
|
US5837821A
(en)
|
1992-11-04 |
1998-11-17 |
City Of Hope |
Antibody construct
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
DE669986T1
(de)
|
1992-11-13 |
1996-10-10 |
Idec Pharma Corp |
Völlig unfunktionelle konsensus-kozak-sequenzen zur säugetier-exprimierung.
|
|
US5676950A
(en)
|
1994-10-28 |
1997-10-14 |
University Of Florida |
Enterically administered recombinant poxvirus vaccines
|
|
DE69525544T2
(de)
|
1994-11-18 |
2002-08-22 |
Neurocrine Biosciences, Inc. |
Peptidanaloga des menschlichen myelinbasischen proteins mit substitution in position 91 zur behandlung von multipler sklerose
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
ES2242997T3
(es)
|
1997-03-14 |
2005-11-16 |
Biogen Idec Inc. |
Metodo para integrar genes en sitios especificos en celulas de mamifero por medio de recombinacion homologa y vectores para realizar el mismo.
|
|
EP2006303A1
(en)
|
1997-04-09 |
2008-12-24 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof
|
|
US20020086847A1
(en)
|
1997-04-09 |
2002-07-04 |
Mindset Biopharmaceuticals (Usa) |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
WO1998052976A1
(en)
|
1997-05-21 |
1998-11-26 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
US6703015B1
(en)
|
1999-09-03 |
2004-03-09 |
Ramot At Tel-Aviv University Ltd. |
Filamentous bacteriophage displaying an β-amyloid epitope
|
|
US6710226B1
(en)
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
|
AU3117799A
(en)
|
1998-03-30 |
1999-10-18 |
Trustees Of The University Of Pennsylvania, The |
Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders
|
|
WO2000030680A1
(en)
|
1998-11-23 |
2000-06-02 |
Idec Pharmaceuticals Corporation |
Tumor antigen-specific antibody-gp39 chimeric protein constructs
|
|
WO2000034317A2
(en)
|
1998-12-08 |
2000-06-15 |
Biovation Limited |
Method for reducing immunogenicity of proteins
|
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
CA2274414A1
(en)
|
1999-06-11 |
2000-12-11 |
Universite Laval |
Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
|
|
JP2003509020A
(ja)
|
1999-09-03 |
2003-03-11 |
ラモット・ユニバーシティ・オーソリティ・フォー・アプライド・リサーチ・アンド・インダストリアル・ディベロップメント・リミテッド |
プラーク形成疾患の診断、治療、予防に有用な薬剤、組成物、その使用法
|
|
US6187309B1
(en)
|
1999-09-14 |
2001-02-13 |
Milkaus Laboratory, Inc. |
Method for treatment of symptoms of central nervous system disorders
|
|
US6294171B2
(en)
|
1999-09-14 |
2001-09-25 |
Milkhaus Laboratory, Inc. |
Methods for treating disease states comprising administration of low levels of antibodies
|
|
US6713058B2
(en)
|
1999-09-14 |
2004-03-30 |
Milkhaus Laboratory, Inc. |
Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies
|
|
US6436401B1
(en)
|
1999-09-14 |
2002-08-20 |
Milkhaus Laboratory, Inc. |
Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies
|
|
ATE446366T1
(de)
|
2000-06-22 |
2009-11-15 |
Genentech Inc |
Agonistische monoklonale antikörper gegen trkc
|
|
EP1309341A2
(en)
|
2000-07-07 |
2003-05-14 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
EP1340088B1
(en)
|
2000-11-17 |
2007-01-17 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
BR0206985A
(pt)
|
2001-01-29 |
2005-04-19 |
Idec Pharma Corp |
Anticorpos modificados e métodos de uso
|
|
AU2002327164A1
(en)
|
2001-01-29 |
2002-12-09 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
|
ITPV20010007U1
(it)
|
2001-07-19 |
2003-01-19 |
Maruscia Food Specialties Comp |
Contenitore per profilattico nuovo e usato
|
|
PT1944040E
(pt)
|
2001-08-17 |
2012-10-31 |
Univ Washington |
Método de avaliação para a doença de alzheimer
|
|
US7414111B2
(en)
|
2001-09-19 |
2008-08-19 |
Alexion Pharmaceuticals, Inc. |
Engineered templates and their use in single primer amplification
|
|
US20030157641A1
(en)
|
2001-11-16 |
2003-08-21 |
Idec Pharmaceuticals Corporation |
Polycistronic expression of antibodies
|
|
GB0203446D0
(en)
|
2002-02-14 |
2002-04-03 |
Univ Lancaster |
Detection and/or monitoring of synuclein-related diseases
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20110200609A1
(en)
|
2002-09-12 |
2011-08-18 |
The Regents Of The University Of California |
Monoclonal antibodies specific for pathological amyloid aggregates common to amyloids formed from proteins of differing sequence
|
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
|
US20080014194A1
(en)
|
2003-10-31 |
2008-01-17 |
Elan Pharmaceuticals, Inc. |
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
|
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
|
DE60331101D1
(de)
|
2002-11-22 |
2010-03-11 |
Chugai Pharmaceutical Co Ltd |
Antikörper gegen geschädigtes gewebe
|
|
US20060240485A1
(en)
|
2003-04-24 |
2006-10-26 |
Universitat Zurich |
Method of monitoring immunotherapy
|
|
PE20050627A1
(es)
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
|
WO2005018424A2
(en)
|
2003-08-18 |
2005-03-03 |
Research Foundation For Mental Hygiene, Inc. |
Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
|
|
CN1871259A
(zh)
|
2003-08-22 |
2006-11-29 |
比奥根艾迪克Ma公司 |
具有改变的效应物功能的经改进的抗体和制备它的方法
|
|
US20070031416A1
(en)
|
2003-09-09 |
2007-02-08 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
WO2005047860A2
(en)
|
2003-11-08 |
2005-05-26 |
Elan Pharmaceuticals, Inc. |
Antibodies to alpha-synuclein
|
|
AU2005217596B2
(en)
|
2004-02-23 |
2012-01-19 |
Eli Lilly And Company |
Anti-ABeta antibody
|
|
WO2005105998A1
(ja)
|
2004-04-27 |
2005-11-10 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
ヒト抗アミロイドβペプチド抗体およびその抗体フラグメント
|
|
DE602005022871D1
(de)
|
2004-06-07 |
2010-09-23 |
Univ Ramot |
Verfahren zur passiven immunisierung gegen eine durch amyloidaggregation gekennzeichnete krankheit oder erkrankung mit vermindertem nervenentzündungsrisiko
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
MX2007001679A
(es)
|
2004-08-09 |
2007-05-23 |
Elan Pharm Inc |
Prevencion y tratamiento de la enfermedad sinucleinopatica y amiloidogenica.
|
|
WO2006050041A2
(en)
|
2004-10-28 |
2006-05-11 |
Ramot At Tel Aviv University Ltd. |
Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis
|
|
TW200636066A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1838349A1
(en)
|
2004-12-15 |
2007-10-03 |
Neuralab, Ltd. |
Amyloid beta antibodies for use in improving cognition
|
|
WO2006094724A2
(en)
|
2005-03-05 |
2006-09-14 |
Abbott Gmbh & Co. Kg |
Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
|
|
JP2006265189A
(ja)
|
2005-03-24 |
2006-10-05 |
Kyoto Univ |
βアミロイドペプチド、及びそれを用いたアルツハイマー病治療薬又は予防薬のスクリーニング方法
|
|
ES2318918B1
(es)
|
2005-04-01 |
2010-02-16 |
Biotherapix Molecular Medicines, S.L.U. |
Anticuerpos humanos con capacidad de union al peptido beta-amiloide y sus aplicaciones.
|
|
WO2006116192A2
(en)
|
2005-04-21 |
2006-11-02 |
Medarex, Inc. |
Irta-1 antibodies and their uses
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
ITMI20050912A1
(it)
|
2005-05-19 |
2006-11-20 |
Erregierre Spa |
Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
|
|
CA2657953A1
(en)
|
2005-07-19 |
2007-01-25 |
University Of Rochester |
Alpha-synuclein antibodies and methods related thereto
|
|
WO2007021255A1
(en)
|
2005-08-09 |
2007-02-22 |
Elan Pharmaceuticals, Inc. |
Antibodies to alpha-synuclein
|
|
WO2008020864A2
(en)
|
2005-11-14 |
2008-02-21 |
The Trustees Of Columbia University In The City Of New York |
Imaging correlates of neurogenesis with mri
|
|
CA2630964A1
(en)
|
2005-11-22 |
2007-05-31 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of alzheimer's and related diseases
|
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
US8263558B2
(en)
|
2005-11-30 |
2012-09-11 |
Abbott Laboratories |
Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
|
|
RU2432362C2
(ru)
|
2005-11-30 |
2011-10-27 |
Эбботт Лэборетриз |
Моноклональные антитела и их применения
|
|
SG10201404801YA
(en)
|
2005-12-12 |
2014-09-26 |
Ac Immune Sa |
Monoclonal antibody
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
KR20120017469A
(ko)
|
2007-01-05 |
2012-02-28 |
유니버시티 오브 취리히 |
질환 특이적 결합 분자 및 표적을 제공하는 방법
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
PL2118300T3
(pl)
|
2007-02-23 |
2015-11-30 |
Prothena Biosciences Ltd |
Zapobieganie i leczenie synukleinopatii i amyloidozy
|
|
US8519106B2
(en)
|
2007-03-13 |
2013-08-27 |
University Of Zurich |
Monoclonal human tumor-specific antibody
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
US20080292625A1
(en)
|
2007-04-18 |
2008-11-27 |
Sally Schroeter |
Prevention and treatment of cerebral amyloid angiopathy
|
|
CN101778867A
(zh)
|
2007-06-08 |
2010-07-14 |
地中海大学 |
用于治疗胰腺肿瘤的组合物和方法
|
|
PT2182983E
(pt)
|
2007-07-27 |
2014-09-01 |
Janssen Alzheimer Immunotherap |
Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados
|
|
US9370531B2
(en)
|
2007-08-31 |
2016-06-21 |
New York University |
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
|
|
WO2009033743A1
(en)
|
2007-09-13 |
2009-03-19 |
University Of Zurich Prorektorat Forschung |
Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
|
|
TW200927761A
(en)
|
2007-09-26 |
2009-07-01 |
U3 Pharma Ag |
Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
|
|
JPWO2009051220A1
(ja)
|
2007-10-19 |
2011-03-03 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
GB0720912D0
(en)
|
2007-10-25 |
2007-12-05 |
Univ Cardiff |
Monoclonal Anitbody for APP
|
|
US8343493B2
(en)
|
2007-10-29 |
2013-01-01 |
Innogenetics N.V. |
Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
|
|
DK2207568T3
(en)
|
2007-11-16 |
2017-09-18 |
Univ Rockefeller |
ANTIBODIES SPECIFIC TO THE PROTOFIBRILE FORM OF BETA AMYLOID PROTEIN
|
|
WO2009085200A2
(en)
|
2007-12-21 |
2009-07-09 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
|
AT506535B1
(de)
|
2008-02-22 |
2010-04-15 |
Affiris Forschungs & Entwicklungs Gmbh |
Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
|
|
PT2282758T
(pt)
|
2008-04-29 |
2019-02-12 |
Bioarctic Ab |
Anticorpos e vacinas para uso em métodos terapêuticos e diagnósticos para perturbações relacionadas com a alfa-sinucleína
|
|
CA2730073A1
(en)
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
CA2737667A1
(en)
|
2008-09-19 |
2010-03-25 |
Medimmune, Llc |
Targeted binding agents directed to cd105 and uses thereof
|
|
PL2365804T3
(pl)
|
2008-11-13 |
2015-10-30 |
Modgene Llc |
Zmniejszanie obciążenia amyloidem-beta w tkance niemózgowej
|
|
AU2009328505B2
(en)
|
2008-12-19 |
2014-11-27 |
Panima Pharmaceuticals Ag |
Human anti-alpha-synuclein autoantibodies
|
|
US20100256596A1
(en)
|
2009-04-07 |
2010-10-07 |
Cabochon Aesthetics, Inc. |
Fiber growth promoting implants for reducing the appearance of cellulite
|
|
CN102459335B
(zh)
|
2009-04-17 |
2015-11-25 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
ES2624835T3
(es)
|
2009-08-06 |
2017-07-17 |
Immunas Pharma, Inc. |
Anticuerpos que se unen específicamente a los oligómeros A beta y uso de los mismos
|
|
JP5599454B2
(ja)
|
2009-08-06 |
2014-10-01 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
WO2011028771A2
(en)
|
2009-09-02 |
2011-03-10 |
E. I. Du Pont De Nemours And Company |
Polyester films with improved oil repellency
|
|
HUE041391T2
(hu)
|
2011-06-23 |
2019-05-28 |
Biogen Int Neuroscience Gmbh |
Anti-alfa-szinukleinkötõ molekulák
|
|
US20140295465A1
(en)
|
2011-11-02 |
2014-10-02 |
Biogen Idec International Neuroscience Gmbh |
USE OF AN ANTI-alpha-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF alpha-SYNUCLEIN IN THE BRAIN
|
|
ITRM20120383A1
(it)
|
2012-03-20 |
2013-09-21 |
Uni Degli Studi Di Milano B Icocca |
Metodo e kit per la rivelazione di anticorpi.
|
|
JOP20190227A1
(ar)
|
2017-03-31 |
2019-09-30 |
Biogen Int Neuroscience Gmbh |
تركيبات وطرق لعلاج اعتلالات السينوكلين
|